Here are three things to know:
1. Mr. Cook has more than 25 years of experience. He led the asset purchase of International Biologics, renamed Lattice Biologics, in September 2013.
2. He founded and developed Bacterin International from a small contract research and development startup to a publicly-traded multinational organization with sales in over 15 countries, a multimillion dollar revenue and more than 150 employees.
3. Mr. Cook spent more 18 years in the tissue engineering field, beginning his career as a confocal microscopist scientist.
More articles on biologics:
Cellect receives patent approval for Apograft technology: 3 notes
OsteoRemedies unveils 1st FDA-cleared dual-antibiotic spacer & bone cement: 3 notes
MTF Biologics & Academy Medical join forces to bring allografts to the VA: 4 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
